Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China
- PMID: 25671102
- PMCID: PMC4323338
- DOI: 10.1186/2047-9158-3-26
Prevalence of wearing-off and dyskinesia among the patients with Parkinson's disease on levodopa therapy: a multi-center registry survey in mainland China
Abstract
Objective: Chronic levodopa (L-dopa) treatment in Parkinson's disease (PD) is often associated with the development of motor complications, but the corresponding epidemiological data is rare in Chinese PD patients. The present survey was to investigate the prevalence rate of wearing-off (WO) and dyskinesia among the patients with PD in China.
Methods: From May 2012 to October 2012, a 3-step registry survey for wearing off (WO) and dyskinesia patients with PD receiving levodopa therapy was performed simultaneously at 28 movement disorders clinics in China.
Results: There were 1,558 PD patients fulfilling the inclusion criteria. Among them, 1,051 had at least one positive response of 9-item wearing off questionnaire (WOQ-9), 724 and 160 patients were finally diagnosed with WO and dyskinesia by movement disorders specialists, respectively. The overall prevalence rates of WO and dyskinesia were 46.5% (95% CI 44.0% - 48.9%) and 10.3% (95% CI 8.8% - 11.8%), respectively. The mean score of WOQ-9 for those with WO was 3.8 (SD = 1.8), with movement slowness being the most common motor symptoms and pain/aching being the most common non-motor symptoms. Better improvement of motor symptoms (n = 354, 87.8%) and long-term disease control and drug selection (n = 288, 71.5%) were the two most frequently considered factors when movement disorders specialists adjusted therapeutic strategies for patients with WO.
Conclusions: This survey provided the first multi-center epidemiological data of motor complications among PD patients on L-dopa therapy from mainland China. WO prevalence rate among Chinese PD patients was in line with, while dyskinesia prevalence rate was lower than previous reports from other Countries.
Keywords: Dyskinesia; Epidemiology; Parkinson’s disease; Wearing-off.
Figures



Similar articles
-
Early DEtection of wEaring off in Parkinson disease: the DEEP study.Parkinsonism Relat Disord. 2014 Feb;20(2):204-11. doi: 10.1016/j.parkreldis.2013.10.027. Epub 2013 Nov 5. Parkinsonism Relat Disord. 2014. PMID: 24275586
-
Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.Mov Disord. 2013 Jul;28(8):1064-71. doi: 10.1002/mds.25364. Epub 2013 Apr 29. Mov Disord. 2013. PMID: 23630119 Clinical Trial.
-
Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?J Neural Transm (Vienna). 2012 Mar;119(3):373-80. doi: 10.1007/s00702-011-0683-9. Epub 2011 Jul 17. J Neural Transm (Vienna). 2012. PMID: 21769622
-
Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.Ann Pharmacother. 2007 Nov;41(11):1842-9. doi: 10.1345/aph.1K348. Epub 2007 Sep 18. Ann Pharmacother. 2007. PMID: 17878397 Review.
-
Treatment of Parkinson's disease: levodopa as the first choice.J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4. J Neurol. 2002. PMID: 12375059 Review.
Cited by
-
Wearing-off Identification in Parkinson's Disease: The shapd-woq Study.Front Neurol. 2020 Mar 13;11:116. doi: 10.3389/fneur.2020.00116. eCollection 2020. Front Neurol. 2020. PMID: 32231634 Free PMC article.
-
Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson's Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study.J Mov Disord. 2023 May;16(2):180-190. doi: 10.14802/jmd.22196. Epub 2023 Apr 26. J Mov Disord. 2023. PMID: 37096301 Free PMC article.
-
Adjunct rasagiline to treat Parkinson's disease with motor fluctuations: a randomized, double-blind study in China.Transl Neurodegener. 2018 Jun 30;7:14. doi: 10.1186/s40035-018-0119-7. eCollection 2018. Transl Neurodegener. 2018. PMID: 29988514 Free PMC article.
-
Identifying Risk Factors and Constructing Predictive Models for Wearing-Off and Dyskinesia in Chinese Patients With Parkinson's Disease on Long-Term Levodopa Therapy.CNS Neurosci Ther. 2025 Aug;31(8):e70544. doi: 10.1111/cns.70544. CNS Neurosci Ther. 2025. PMID: 40785408 Free PMC article.
-
Analysis of Motor Complication and Relative Factors in a Cohort of Chinese Patients with Parkinson's Disease.Parkinsons Dis. 2020 Jul 29;2020:8692509. doi: 10.1155/2020/8692509. eCollection 2020. Parkinsons Dis. 2020. PMID: 32802308 Free PMC article.
References
-
- Liu CF, Yin WH, Luo WF. Factors of dyskinesias and motor fluctuations in Parkinson's disease. Chin J Neurol. 2003;36:411–413.
LinkOut - more resources
Full Text Sources
Other Literature Sources